Results 181 to 190 of about 7,577 (211)

Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study [PDF]

open access: yesEuropean Heart Journal, 2021
AbstractAims The potential difference in the impacts of lifestyle factors (LFs) on progression from healthy to first cardiometabolic disease (FCMD), subsequently to cardiometabolic multimorbidity (CMM), and further to death is unclear.Methods and results We used data from the China Kadoorie Biobank of 461 047 adults aged 30–79 free of heart disease ...
Yizhen Hu, Canqing Yu, Ling Yang
exaly   +4 more sources

Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018

open access: yesInternational Journal of Environmental Research and Public Health, 2022
Cardiometabolic multimorbidity (co-existence of ≥1 cardiometabolic diseases) is increasingly common, while its prevalence in the U.S. is unknown. We utilized data from 10 National Health and Nutrition Examination Survey (NHANES) two-year cycles in U.S. adults from 1999 to 2018.
XunJie Cheng   +2 more
exaly   +3 more sources

Role of Pulmonary Function in Predicting New-Onset Cardiometabolic Diseases and Cardiometabolic Multimorbidity

Chest, 2022
Although pulmonary function has been studied in relationship to individual cardiometabolic diseases, uncertainty persists about the difference in risk magnitudes of pulmonary function for these diseases and its association with cardiometabolic multimorbidity (CM).Does pulmonary function have different risk magnitudes for cardiometabolic diseases and CM?
Guochen Li, Yanqiang Lu, Yanan Qiao
exaly   +3 more sources

Cardiometabolic multimorbidity, genetic risk and dementia

Alzheimer's & Dementia, 2022
AbstractBackgroundThe extent to which multiple cardiovascular and metabolic co‐morbidity and genetic factors combine or interact to increase dementia risk is unknown.MethodWe analysed 435 105 participants from the UK Biobank prospective cohort of European ancestry, aged 40 to 72 years, without dementia at baseline (2006‐2010), followed until 2021.
Tai, Xin You   +7 more
openaire   +2 more sources

Correlation of cardiometabolic index and sarcopenia with cardiometabolic multimorbidity in middle-aged and older adult: a prospective study

open access: yesFrontiers in Endocrinology
BackgroundResearch has demonstrated that sarcopenia and visceral obesity are significant risk factors for chronic disease in middle-aged and older adults. However, the relationship between sarcopenia, the cardiac metabolic index (CMI), a novel measure of visceral obesity, and cardiometabolic multimorbidity (CMM) remains unclear.
Chuyang Lin, Yazhi Yang
exaly   +4 more sources

Accelerated biological aging: unveiling the path to cardiometabolic multimorbidity, dementia, and mortality

open access: yesFrontiers in Public Health
BackgroundCardiometabolic multimorbidity (CMM) and aging are increasing public health concerns. This prospective study used UK Biobank cohort to investigate the relationship between biological aging and the trajectory of CMM to dementia and mortality.MethodsCMM is the coexistence of at least two cardiometabolic diseases (CMD), including stroke ...
Yu Jia, Zhi Wan, Dongze Li
exaly   +4 more sources

Accelerated biological aging elevates the risk of cardiometabolic multimorbidity and mortality

Nature Cardiovascular Research
Associations of biological aging with the development and mortality of cardiometabolic multimorbidity (CMM) remain unclear. Here we conducted a multistate analysis in 341,159 adults of the UK Biobank. CMM was defined as the coexistence of two or three cardiometabolic diseases (CMDs), including type 2 diabetes, ischemic heart disease and stroke ...
Meijie Jiang   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy